Literature DB >> 12147436

Metastasis to and from the central nervous system--the 'relatively protected site'.

A Subramanian1, A Harris, K Piggott, C Shieff, R Bradford.   

Abstract

The brain has long been recognised as a site with a very low rate of metastases, despite the potential for cancers to be extremely locally aggressive. This feature contrasts with most of the rest of the body, where metastatic spread is much more common. The pathological behaviour of any tumour is governed by both its inherent composition and the composition of the matrix in which it is sited. Much work has been done in recent years to elucidate the factors within the central nervous system (CNS) that give the brain its unique properties. Tumour interactions with the blood-brain barrier, microglia, and various matrix proteins, cytokines, and growth factors have a central role. This review concentrates mainly on the process of tumour spread from the CNS and explores how the brain is a protected site. CNS metastases from extraneural sites are also briefly covered.

Entities:  

Mesh:

Year:  2002        PMID: 12147436     DOI: 10.1016/s1470-2045(02)00819-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  31 in total

1.  Mediastinal metastasis of glioblastoma multiforme evolving from anaplastic astrocytoma.

Authors:  Hannu Tuominen; Jouni Lohi; Abdel Maiche; Juhani Törmänen; Peter Baumann
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

Review 2.  Brain metastasis in pediatric extracranial solid tumors: survey and literature review.

Authors:  Rejin Kebudi; Inci Ayan; Omer Görgün; Fulya Yaman Ağaoğlu; Sema Vural; Emin Darendeliler
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  Probing the mechanical properties of brain cancer cells using a microfluidic cell squeezer device.

Authors:  Z S Khan; S A Vanapalli
Journal:  Biomicrofluidics       Date:  2013-01-10       Impact factor: 2.800

4.  The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.

Authors:  Qian-Xia Li; Xiao Zhou; Ting-Ting Huang; Yang Tang; Bo Liu; Ping Peng; Li Sun; Yi-Hua Wang; Xiang-Lin Yuan
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

5.  A rare case of esophageal cancer (T2N0) with a solitary cerebellar metastasis.

Authors:  Yasuhiro Ohtsuka; Kazumi Hatayama; Teisuke Komatsu; Takeshi Ogasawara; Takashi Shida; Shigeharu Nakano; Satoru Nomura; Yoshiharu Sato; Makoto Takahashi; Fukuo Kondo
Journal:  Clin J Gastroenterol       Date:  2011-10-08

6.  Oligodendroglioma metastatic to bone marrow.

Authors:  Firas Al-Ali; Aaron J Hendon; Marcia K Liepman; Jennifer L Wisniewski; Mark J Krinock; Kevin Beckman
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 7.  Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.

Authors:  Shreyas S Rao; John J Lannutti; Mariano S Viapiano; Atom Sarkar; Jessica O Winter
Journal:  Tissue Eng Part B Rev       Date:  2013-10-30       Impact factor: 6.389

8.  Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion.

Authors:  Bin Hu; Keerthi K Thirtamara-Rajamani; Hosung Sim; Mariano S Viapiano
Journal:  Mol Cancer Res       Date:  2009-11-03       Impact factor: 5.852

9.  Molecular diagnosis of metastasizing oligodendroglioma: a case report.

Authors:  Min Wang; Kathleen M Murphy; Piotr Kulesza; Kimmo J Hatanpaa; Alessandro Olivi; Anthony Tufaro; Yener Erozan; William H Westra; Peter C Burger; Karin D Berg
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

10.  The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility.

Authors:  Bin Hu; Leopold L Kong; Russell T Matthews; Mariano S Viapiano
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.